🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 16 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/11/2007 15,54 15,54 13,80 15,00 -0,79% 11,20% 53.567
19/11/2007 15,18 15,54 15,00 15,12 -1,56% 3,56% 31.733
16/11/2007 15,90 16,20 15,18 15,36 -3,76% 6,42% 42.383
15/11/2007 16,44 16,92 15,96 15,96 -3,97% 5,84% 24.767
14/11/2007 16,02 17,16 15,60 16,62 +4,53% 9,74% 69.133
13/11/2007 15,42 16,08 15,18 15,90 +5,16% 5,84% 42.633
12/11/2007 14,76 15,36 14,76 15,12 +2,86% 4,07% 57.183
09/11/2007 14,70 15,06 14,40 14,70 -2,00% 4,49% 60.650
08/11/2007 15,24 15,54 14,70 15,00 +0,00% 5,51% 53.367
07/11/2007 15,36 15,48 14,76 15,00 -3,47% 4,69% 93.467
06/11/2007 15,78 16,74 15,42 15,54 -3,36% 8,37% 70.250
05/11/2007 16,02 16,14 15,78 16,08 -0,74% 2,25% 43.317
02/11/2007 16,26 16,80 16,02 16,20 -1,82% 4,80% 42.483
01/11/2007 17,40 17,52 16,32 16,50 -2,83% 6,90% 50.217
31/10/2007 16,86 17,10 16,86 16,98 +0,35% 1,42% 19.533
30/10/2007 17,10 17,22 16,92 16,92 -0,35% 1,75% 19.767
29/10/2007 17,58 17,58 16,86 16,98 -3,74% 4,10% 26.350
26/10/2007 17,04 17,64 16,86 17,64 +3,16% 4,58% 40.767
25/10/2007 17,70 17,70 16,80 17,10 -3,06% 5,08% 42.367
24/10/2007 17,40 17,64 17,10 17,64 +1,38% 3,10% 42.700
23/10/2007 17,58 17,64 17,10 17,40 -1,02% 3,07% 21.950
22/10/2007 16,92 17,58 16,80 17,58 +2,81% 4,61% 27.917
19/10/2007 17,40 17,40 17,10 17,10 -2,40% 1,72% 29.817
18/10/2007 17,40 18,00 17,16 17,52 -0,68% 4,83% 42.833
17/10/2007 17,34 17,70 17,10 17,64 +2,80% 3,46% 42.433
16/10/2007 17,16 17,70 16,98 17,16 +0,35% 4,20% 44.517
15/10/2007 17,70 17,76 17,10 17,10 -1,04% 3,73% 37.233
12/10/2007 17,58 17,64 17,04 17,28 -0,69% 3,41% 45.433
11/10/2007 17,58 18,06 17,40 17,40 -1,69% 3,75% 60.317
10/10/2007 18,36 18,84 16,92 17,70 -3,91% 10,46% 131.533